Skip to main navigation
Skip to search
Skip to main content
5th Annual EMBL Australia Postgraduate Symposium
Acute Lymphoblastic Leukamia (ALL) Research Group
Tavakoli PS, Eadie LN, Heatley SL, White DW.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Oral and Poster Presentation
28 Nov 2018
30 Nov 2018